Correlation Between Aikido Pharma and CRISPR Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aikido Pharma and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aikido Pharma and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aikido Pharma and CRISPR Therapeutics AG, you can compare the effects of market volatilities on Aikido Pharma and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aikido Pharma with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aikido Pharma and CRISPR Therapeutics.

Diversification Opportunities for Aikido Pharma and CRISPR Therapeutics

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between Aikido and CRISPR is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Aikido Pharma and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and Aikido Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aikido Pharma are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of Aikido Pharma i.e., Aikido Pharma and CRISPR Therapeutics go up and down completely randomly.

Pair Corralation between Aikido Pharma and CRISPR Therapeutics

Given the investment horizon of 90 days Aikido Pharma is expected to generate 1.15 times more return on investment than CRISPR Therapeutics. However, Aikido Pharma is 1.15 times more volatile than CRISPR Therapeutics AG. It trades about 0.15 of its potential returns per unit of risk. CRISPR Therapeutics AG is currently generating about -0.03 per unit of risk. If you would invest  609.00  in Aikido Pharma on June 28, 2022 and sell it today you would earn a total of  63.00  from holding Aikido Pharma or generate 10.34% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Aikido Pharma  vs.  CRISPR Therapeutics AG

 Performance (%) 
       Timeline  
Aikido Pharma 
Aikido Performance
8 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Aikido Pharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly abnormal forward-looking signals, Aikido Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Aikido Price Channel

CRISPR Therapeutics 
CRISPR Performance
0 of 100
Over the last 90 days CRISPR Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, CRISPR Therapeutics is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the insiders.

CRISPR Price Channel

Aikido Pharma and CRISPR Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aikido Pharma and CRISPR Therapeutics

The main advantage of trading using opposite Aikido Pharma and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aikido Pharma position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.
Aikido Pharma vs. Clearwater Paper Corp
The idea behind Aikido Pharma and CRISPR Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
CRISPR Therapeutics vs. Clearwater Paper Corp
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go